Leisure-time physical activity is associated with the metabolic syndrome in type 1 diabetes -: Effect of the PPARγ Pro12Ala polymorphism:: the FinnDiane Study

被引：11
作者：
Waden, Johan
Thorn, Lena M.
Forsblom, Carol
Lakka, Timo
Saraheimo, Markku
Rosengard-Barlund, Milla
Heikkila, Outi
Wessman, Maija
Turunen, Joni A.
Parkkonen, Maija
Tikkanen, Heikki
Groop, Per-Henrik
机构：
[1] Folkhalsam Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, Helsinki, Finland
[3] Univ Kuopio, Inst Biomed, Dept Physiol, FIN-70211 Kuopio, Finland
[4] Kuopio Res Inst Exercise Med, FIN-70211 Kuopio, Finland
[5] Univ Helsinki, Finnish Genome Ctr, FIN-00014 Helsinki, Finland
[6] Univ Helsinki, Inst Clin Med, Unit Sports & Exercise Med, FIN-00014 Helsinki, Finland
来源：
DIABETES CARE | 2007年 / 30卷 / 06期
关键词：
D O I：
10.2337/dc06-2467
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1618 / 1620
页数：3
相关论文
共 21 条
[1]   Influence of Pro12Ala peroxisome proliferator-activated receptor γ2 polymorphism on glucose response to exercise training in type 2 diabetes [J].
Adamo, KB ;
Sigal, RJ ;
Williams, K ;
Kenny, G ;
Prud'homme, D ;
Tesson, F .
DIABETOLOGIA, 2005, 48 (08) :1503-1509
[2]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[3]   Metabolic syndrome: dietary interventions [J].
Aude, YW ;
Mego, P ;
Mehta, JL .
CURRENT OPINION IN CARDIOLOGY, 2004, 19 (05) :473-479
[4]   The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes - Results from Metascreen, a multicenter diabetes clinic-based survey [J].
Bonadonna, Riccarcdo C. ;
Cucinotta, Domenico ;
Fedele, Domenico ;
Riccardi, Gabriele ;
Tiengo, Antonio .
DIABETES CARE, 2006, 29 (12) :2701-2707
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[7]  
Eriksson J, 1997, DIABETOLOGIA, V40, P125
[8]   Studies of the Pro12Ala polymorphism of the PPAR-γ gene in the Danish MONICA cohort:: Homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome [J].
Frederiksen, L ;
Brodbæk, K ;
Fenger, M ;
Jorgensen, T ;
Borch-Johnsen, K ;
Madsbad, S ;
Urhammer, SA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3989-3992
[9]   Prevalence of the metabolic syndrome and its components -: Findings from a Finnish general population sample and the Diabetes Prevention Study cohort [J].
Ilanne-Parikka, P ;
Eriksson, JG ;
Lindström, J ;
Hämäläinen, H ;
Keinänen-Kiukaanniemi, S ;
Laakso, M ;
Loutheranta, A ;
Mannelin, M ;
Rastas, M ;
Salminen, V ;
Aunola, S ;
Sundvall, J ;
Valle, T ;
Lahtela, J ;
Uusitupa, M ;
Tuomilehto, J .
DIABETES CARE, 2004, 27 (09) :2135-2140
[10]   Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].
Isomaa, B ;
Almgren, P ;
Tuomi, T ;
Forsén, B ;
Lahti, K ;
Nissén, M ;
Taskinen, MR ;
Groop, L .
DIABETES CARE, 2001, 24 (04) :683-689
123